Financial Toxicity

Do No Financial Harm: How to Improve Cost Transparency in Cancer Care

Chase Doyle

February 2019, Vol 9, No 2 - Financial Toxicity

We’ve heard the figures before: the price of cancer drugs has risen by orders of magnitude per month over the past decades, deductibles have tripled in the past 6 years, and employer contribution to premiums has increased by nearly 300% over the past 15 years. In addition to cancer treatment becoming more expensive, insurance design and drug formularies have changed, resulting in a greater financial burden for patients. [ Read More ]